A Phase II, Randomized, Double-blind, Placebo-controlled Study to Examine the Effects of DAS181 in Immunocompromised Subjects With Lower Respiratory Tract Parainfluenza Infection on Supplemental Oxygen

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2014
This protocol will seek to enroll immunocompromised patients who are on supplemental oxygen and diagnosed with a parainfluenza infection.
Epistemonikos ID: 10533dff40b6c30880c13f6c56e0fd3622a8d231
First added on: May 11, 2024